Newly released pictures show then-Vice President Joe Biden meeting some of his son Hunter Biden’s Chinese business partners during an official visit to the country, as well as Hunter meeting ...

Here we take a look back at this year in pictures. Image: 3 January: Luke Littler, 16, loses to Luke Humphries in the final of the Paddy Power World Darts Championship at Alexandra Palace in London.

The National Park Service has awarded a $75,000 grant to the Emmett Till Interpretive Center in Sumner. Rep. Bennie Thompson made the announcement Wednesday.The funding will support the documentation ...

Novo Nordisk’s shares recovered some ground on Monday after a 27% slump on Friday in response to an underwhelming set of results from a Phase III trial of its new weight-loss drug CagriSema, but ...

Novo Nordisk has announced its latest trial result for the new obesity drug, CagriSema, which disappointed investors and sent its share price plunging 20% in Denmark on Friday, the sharpest one ...

Her photos of the endangered Antillean manatee were exhibited in the Dominican Museum for Natural History. Follow Christian on instagram @christianvizl. Credit: Christian Vizl /Courtesy of Vital ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...

LISBON, Jan 15 (Reuters) - U.S. private equity fund Lone Star and Portuguese authorities are set to share 1.3 billion euros ($1.34 billion) when Novo Banco makes its first dividend payout in the ...

We list the best Google Photos alternatives, to make it simple and easy to backup your photos safely and securely. The best Google Photos alternatives offer many of the features found in the ...

As we pause to remember King’s legacy, here’s a look back at his defining years in pictures.

Bagsværd, Denmark-based Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market with a full portfolio of glucagon-like peptide 1 (GLP-1) receptor agonists ...

Novo Nordisk recently announced results for a new weight loss candidate, CagriSema. Data from the trial underwhelmed investors, and Novo stock is down almost 20% on the news. However, investors ...